β-Amyloid Peptides Initiate the Complement Cascade without Producing a Comparable Effect on the Terminal Pathwayin Vitro
- 31 August 1997
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 146 (2) , 388-394
- https://doi.org/10.1006/exnr.1997.6540
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinPublished by Elsevier ,2004
- The nanometer-scale structure of amyloid-Β visualized by atomic force microscopyProtein Journal, 1996
- Enhanced cytotoxicity of amyloid β-peptide by a complement dependent mechanismNeuroscience Letters, 1994
- Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer's diseaseResearch in Immunology, 1992
- Complement proteins and complement inhibitors in Alzheimer's diseaseResearch in Immunology, 1992
- A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's DiseaseScience, 1991
- Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal culturesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Complement activation by immunoglobulin does not depend solely on C1q bindingEuropean Journal of Immunology, 1990
- Complement activation in amyloid plaques in Alzheimer’s dementiaVirchows Archiv B Cell Pathology Including Molecular Pathology, 1988
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.The Journal of Experimental Medicine, 1987